Literature DB >> 8330290

Inhibitory effects of ascorbic acid on growth of leukemic and lymphoma cell lines.

T L Kao1, W J Meyer, J F Post.   

Abstract

Vitamin C has been suggested and disputed as an anti-cancer agent. Previous in vitro studies using either primary cell cultures from cancer patients or tumor cell lines have suggested that tumor cells with different lineages may have different sensitivities to ascorbic acid. In this study we report characterization of the effects of ascorbic acid on growth of two ascorbic acid sensitive and one ascorbic acid resistant lymphocyte tumor cell lines. The cytotoxic effects of ascorbic acid on the sensitive cell lines were time and dosage dependent. Furthermore, the energy state of the ascorbic acid sensitive cells was affected by the presence of ascorbic acid before the cells became apparently non-viable, as demonstrated by 31P nuclear magnetic resonance spectroscopy. The existence of these lymphocyte cell lines with varying sensitivities to ascorbic acid may provide a useful model system for further understanding of vitamin C action on cancer cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8330290     DOI: 10.1016/0304-3835(93)90080-s

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  2 in total

1.  Vitamin C effect on mitoxantrone-induced cytotoxicity in human breast cancer cell lines.

Authors:  Eliana Guerriero; Angela Sorice; Francesca Capone; Virginia Napolitano; Giovanni Colonna; Gabriella Storti; Giuseppe Castello; Susan Costantini
Journal:  PLoS One       Date:  2014-12-22       Impact factor: 3.240

2.  Enhanced Anticancer Effect of Adding Magnesium to Vitamin C Therapy: Inhibition of Hormetic Response by SVCT-2 Activation.

Authors:  Sungrae Cho; Jin Sung Chae; Hocheol Shin; Yujeong Shin; Youngwook Kim; Eui-Joon Kil; Hee-Seong Byun; Sang-Ho Cho; Seyeon Park; Sukchan Lee; Chang-Hwan Yeom
Journal:  Transl Oncol       Date:  2019-12-31       Impact factor: 4.243

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.